Selank

• 5mg lyophilized peptide

• Anxiolytic effects through modulation of serotonin receptor activity, supporting calmness, emotional stability, and stress resilience without the sedative profile seen with traditional anxiolytics.
• Cognitive enhancement through increased brain-derived neurotrophic factor (BDNF) signaling, supporting neuroplasticity, learning, memory retention, and mental clarity.
• Immune modulation through regulation of cytokine activity, which may contribute to overall stress resistance and mood stability in research models.

• Stress and anxiety reduction signals that may mitigate chronic stress, anxiety, and depression related endpoints, including in high-stress lifestyle and generalized anxiety disorder (GAD) research frameworks.
• Cognitive enhancement signals that may improve focus, mental clarity, and learning ability in performance and productivity oriented paradigms.
• Mood stabilization and emotional resilience signals that may help regulate emotional responses in research contexts relevant to PTSD, ADHD, and other neuropsychiatric conditions.

Selank is generally described as well tolerated in research settings, with minimal reported side effects. Unlike benzodiazepines or sedatives, Selank is described as not causing dependence, withdrawal, or cognitive impairment in research applications.

• Intranasal use may cause mild nasal irritation.
• Mild drowsiness can occur in sensitive individuals.
• Rare headaches may occur and are typically described as resolving with continued use.

• Commonly combined in research with Semax for dual-action cognitive support
• May complement mitochondrial or neuroprotective peptides
• No negative interactions documented in research literature